Regulatory and Washington

03/26/2014 - 9:58am

CVS Caremark has been awarded a three-year contract to provide integrated PBM for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program.

03/26/2014 - 9:30am

GlaxoSmithKline began alerting consumers that some bottles of its Alli over-the-counter weight-loss medication have been tampered with.

03/25/2014 - 2:32pm

Mylan on Monday announced the U.S. District Court for the Northern District of West Virginia ruled in favor of upholding the validity of patents protecting Perforomist (formoterol fumarate) Inhalation Solution.

03/25/2014 - 7:55am

The Food and Drug Administration last week approved Amneal Pharmaceuticals' abbreviated new drug application for atovaquone oral suspension USP, 750-mg/5-mL.

03/24/2014 - 1:59pm

As the March 31 enrollment deadline draws near, CVS/pharmacy and Ralphs grocery chain have inked deals with the Covered California exchange to promote the healthcare law inside their retail outlets, the Los Angeles Times has reported.

03/21/2014 - 12:35pm

Rx Response earlier this week established a new membership structure that will enable individual companies in the bio-pharmaceutical supply chain to become direct members.

03/21/2014 - 10:46am

Advanced Care Scripts, a division of Omnicare Specialty Care Group, on Friday announced that it has been awarded specialty pharmacy accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization.

03/20/2014 - 2:01pm

The Consumer Healthcare Products Association on Wednesday released the results of a recent poll of Missouri voters conducted by GS Strategy Group and supported by CHPA that found a clear majority of state residents oppose proposed legislation that would require a prescription for the purchase of pseudoephedrine.

03/20/2014 - 11:39am

Mallinckrodt, a specialty pharmaceuticals company, announced the completion of its acquisition of Cadence Pharmaceuticals for approximately $1.4 billion.

03/19/2014 - 12:51pm

Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle.